Alx Oncology Holdings (ALXO) Common Equity (2019 - 2026)
Alx Oncology Holdings (ALXO) recorded Common Equity of $136.19 million in Q2 2026, up 111.4% from $64.42 million a year earlier but down 10.0% from the prior quarter.
Alx Oncology Holdings (ALXO) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Alx Oncology Holdings reported Common Equity of $25.98 million, down 77.1% from FY2024.
- Annual Common Equity has declined for five straight years, with a five-year compound annual growth rate of -42.9% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $113.62 million in FY2024 (-40.1%), $189.71 million in FY2023 (-28.0%), $263.46 million in FY2022 (-27.4%) and $363.05 million in FY2021 (-15.5%).
- Quarterly Common Equity has ranged from $25.98 million in Q4 2025 to $385.17 million in Q3 2021 over the past five years.
- On a year-over-year basis, Common Equity rose in two of the last eight quarters, with an average decline of 15.8%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 111.4% in Q2 2026, against a decline of 77.1% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $151.35 million (Q1 2026), $25.98 million (Q4 2025) and $44.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Alx Oncology Holdings | 186.59 Mn | 186.59 Mn | - | 136.19 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 136.19 Mn |
| Mar 31, 2026 | 151.35 Mn |
| Dec 31, 2025 | 25.98 Mn |
| Sep 30, 2025 | 44.80 Mn |
| Jun 30, 2025 | 64.42 Mn |
| Mar 31, 2025 | 88.30 Mn |
| Dec 31, 2024 | 113.62 Mn |
| Sep 30, 2024 | 136.81 Mn |
| Jun 30, 2024 | 159.32 Mn |
| Mar 31, 2024 | 164.20 Mn |
| Dec 31, 2023 | 189.71 Mn |
| Sep 30, 2023 | 168.75 Mn |
| Jun 30, 2023 | 212.69 Mn |
| Mar 31, 2023 | 240.39 Mn |
| Dec 31, 2022 | 263.46 Mn |
| Sep 30, 2022 | 286.96 Mn |
| Jun 30, 2022 | 316.32 Mn |
| Mar 31, 2022 | 343.60 Mn |
| Dec 31, 2021 | 363.05 Mn |
| Sep 30, 2021 | 385.17 Mn |
Alx Oncology Holdings Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ALXO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ALXO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ALXO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();